Attached files
| file | filename |
|---|---|
| S-1/A - FORM S-1/A - Phio Pharmaceuticals Corp. | b88518a6sv1za.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
RXi Pharmaceuticals Corporation
Worcester, MA
Worcester, MA
We hereby consent to the use in the Prospectus constituting a part of this Registration Statement on Amendment
No. 6 of Form S-1 of our report dated October 25, 2011, relating to the financial statements of the Predecessor (RNAi) (the carve-out entity), which is contained in that Prospectus.
We also
hereby consent to the use in the Prospectus constituting a part of
this Registration
Statement on Amendment No. 6 of Form S-1 of our report dated February 10, 2012, relating to
the financial statement of RXi Pharmaceuticals Corporation (Registrant) which is
contained in that Prospectus.
We also consent to the references to us under the caption
“Experts” in the Prospectus.
/s/ BDO USA, LLP
Boston, MA
February 13, 2012
February 13, 2012